Tradestie Institutional Equity Comparison Engine
XPH vs KIE โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
XPH Overall Edge
XPH Captures Institutional Edge (2โ0 Pillars ยท 1โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to SPDR S&P Pharmaceuticals ETF (XPH) driven by superior Momentum & Technical, Options & Structure. Fundamentally, XPH trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus KIE at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, XPH sits in UNCLASSIFIED (5th %ile IV; Dealer Gamma Walls on Pro) against KIE sits in UNCLASSIFIED (40th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
XPH N/M vs KIE N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
XPH
1Y +30.6% vs +11.5% ยท 52W Pos 64% vs 91%
Options & Structure Winner
XPH
UNCLASSIFIED (5th %ile IV) vs UNCLASSIFIED (40th %ile IV)
XPH
NYSE Arca
SPDR S&P Pharmaceuticals ETF
Institutional Equity
$65.55
-1.92% 1D
Market Cap
N/A
1M Return
+6.0%
1Y Return
+30.55%
Forward P/E
N/M
Unified AI Score
41.0 / 100
SELL
Tech 37.0
Fund 45.0
Flow 50.0
Mom 50.0
KIE
NYSE Arca
SPDR S&P Insurance ETF
Institutional Equity
$65.93
+0.41% 1D
Market Cap
N/A
1M Return
+5.34%
1Y Return
+11.5%
Forward P/E
N/M
Unified AI Score
38.0 / 100
SELL
Tech 24.0
Fund 31.0
Flow 50.0
Mom 11.1
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
XPH +30.55%
KIE +11.5%
Spread: +19.05 pp (XPH Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
XPH TTM Op. Margin: N/A
KIE TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XPH vs KIE. Trailing 12-month operating profitability (XPH N/A vs KIE N/A) and valuation multiples (XPH N/M vs KIE N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | XPH | KIE | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 64% ($50โ$74) | 91% ($53โ$67) | Stronger Trend | KIE |
| Beta / 30D Volatility Risk Regime | 0.87ฮฒ ยท 33% Vol | 0.00ฮฒ ยท 20% Vol | Lower Realized Risk | KIE |
| Unified Institutional Score Composite Signal | 41.0 / 100 (SELL) | 38.0 / 100 (SELL) | Higher Composite | XPH |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full XPH vs KIE Buy Guide
XPH
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
5th %ile
IV Regime
Compressed (<25th %ile)
KIE
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
40th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither XPH nor KIE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.